Design of an IV Formulation of an Unstable Prodrug Candidate for Prostate Cancer Treatment: Solution Chemistry of N-(glutaryl-hyp-ala-ser-cyclohexylglycyl-gln-ser-leu)-doxorubicin.

Autor: Karki, Shyam B.1 (AUTHOR) skarki@prdus.jnj.com, Treemaneekarn, Varaporn1 (AUTHOR), Ostovic, Drazen2 (AUTHOR), Nerurkar, Maneesh3 (AUTHOR), Almarsson, Örn4 (AUTHOR)
Zdroj: Drug Development & Industrial Pharmacy. Apr2006, Vol. 32 Issue 3, p327-334. 8p. 3 Diagrams, 6 Charts, 3 Graphs.
Databáze: Business Source Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje